Senior Medical Writer - Clinical Operations

Working within the Medical and Clinical Affairs organization, the Senior Medical Writer will be primarily responsible for the preparation of clinical study documents to support Convatec products in a range of pre- to post-market studies across global geographies. The successful Senior Medical Writer will engage cross-functional teams in the creation of these clinical study documents, ensuring best-fit study deliverables in support of Convatec products and the patients we serve.,

• Develop protocols, study reports, and additional clinical investigation materials to support clinical study programs across Convatec Business Units
• Prepare data summaries for internal audiences as well as external HCPs, patients, and regulatory authorities
• Implement Good Clinical Practice in the development of all clinical study documents
• Perform literature searches and reviews to support clinical study design, strategic decision making, novel methods
• Stay current on registered studies and published literature within relevant therapy spaces and advise internal teams accordingly
Travel Requirements This is a remote role with limited travel requirements. Travel within country may include quarterly team meetings at Convatec facilities and/or relevant scientific conferences. This role may involve limited international travel, maximum twice per year.


• BSc + 7-10 years' relevant experience OR MSc + 3-5 years' relevant experience OR PhD or equivalent in an appropriate subject
• Experience in writing clinical study documents
• Trained in Good Clinical Practice
• Knowledge of CTMS and eTMF preferred
• Knowledge of medical device/pharmaceutical industry preferred
• Excellent written communication skills
• Good working knowledge of Embase and PubMed
  
  Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.